BSN: Speaking/Presenting-Abstract/Poster at Mtg for Vidal de la Cruz

Home

News

Calendar

Top 200 Orgs

Top Orgs by Specialty

People, Speakers

About Us

My Profile

How We Rank

What's My Rank?
      What's My Popularity Score?
      In My Orgs?
      In My Specialities?
      In My Geography?
      In My Age?

My Mentors, Collaborators,
Associates, Peers, Buddies

Keep Me Up To Date
Specialty, Keyword,
Geography

People Making News

Latest Research From
Meetings

Recent Postings

People of Consequence (74519)

1. Peter Kowey
Lankenau Hospital
2. Lawrence W. Bassett
University of California
3. Robert S Kerbel
University of Toronto
4. Yehuda Shoenfeld
Sheba Medical Center
5. Paul Weiss
Gala Biotech business unit of Cardinal Health

Orgs of Consequence (21210)

1. University of California
2. Harvard University
3. The Mayo Clinic
4. National Institutes of Health
5. University of California, San Francisco

Terms of Consequence

1. Cells
2. Cancer
3. Genetics
4. Molecular
5. Proteins

View Profile

Vidal de la Cruz

No Speaking/Presenting-Abstract/Poster at Mtg

Site wide Speaking/Presenting-Abstract/Poster at Mtg

Presentation	Event	Month, Year
CPSI-2364: An Orally Efficacious Inhibitor of Proinflammatory Cytokine Production for Autoimmune and Inflammatory Diseases	Anti-inflammatories: Small Molecule Approaches	April, 2010

BiotechScienceNews.com promotes research and ranks life scientists working in the life science spectrum involving biotechnology,
drug discovery, genomics, microbiology, neuroscience, medicine, pharmacology, cell biology, and molecular biology.